Update on Coronary Involvement in Fabry Disease

Abstract Fabry disease is a multisystemic disorder with consequent morbidity and mortality at an early age in patients of both genders. Although renal failure has been previously described as the cause of death with the highest prevalence, recent studies, based on the analysis of the population recorded in the Fabry Registry, reported that 40% of deaths had a cardiovascular origin. Data from the same registry emphasize the high risk for these patients suffering cardiovascular events—particularly acute myocardial infarction—and to the fact that this risk is higher for those patients who need dialysis. Microvascular dysfunction is a constant in patients with Fabry disease, which affects young patients, independently from other cardiac involvement manifestations—such as left ventricular hypertrophy—and from the patient’s gender.

Saved in:
Bibliographic Details
Main Author: Cabrera,Gustavo
Format: Digital revista
Language:English
Published: Latin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT) 2016
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942016000100801
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2326-45942016000100801
record_format ojs
spelling oai:scielo:S2326-459420160001008012019-05-28Update on Coronary Involvement in Fabry DiseaseCabrera,Gustavo Fabry disease coronary involvement microvascular involvement coronary syndromes acute myocardial infarction coronary revascularization Abstract Fabry disease is a multisystemic disorder with consequent morbidity and mortality at an early age in patients of both genders. Although renal failure has been previously described as the cause of death with the highest prevalence, recent studies, based on the analysis of the population recorded in the Fabry Registry, reported that 40% of deaths had a cardiovascular origin. Data from the same registry emphasize the high risk for these patients suffering cardiovascular events—particularly acute myocardial infarction—and to the fact that this risk is higher for those patients who need dialysis. Microvascular dysfunction is a constant in patients with Fabry disease, which affects young patients, independently from other cardiac involvement manifestations—such as left ventricular hypertrophy—and from the patient’s gender.info:eu-repo/semantics/openAccessLatin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT)Journal of Inborn Errors of Metabolism and Screening v.4 20162016-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942016000100801en10.1177/2326409816679427
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Cabrera,Gustavo
spellingShingle Cabrera,Gustavo
Update on Coronary Involvement in Fabry Disease
author_facet Cabrera,Gustavo
author_sort Cabrera,Gustavo
title Update on Coronary Involvement in Fabry Disease
title_short Update on Coronary Involvement in Fabry Disease
title_full Update on Coronary Involvement in Fabry Disease
title_fullStr Update on Coronary Involvement in Fabry Disease
title_full_unstemmed Update on Coronary Involvement in Fabry Disease
title_sort update on coronary involvement in fabry disease
description Abstract Fabry disease is a multisystemic disorder with consequent morbidity and mortality at an early age in patients of both genders. Although renal failure has been previously described as the cause of death with the highest prevalence, recent studies, based on the analysis of the population recorded in the Fabry Registry, reported that 40% of deaths had a cardiovascular origin. Data from the same registry emphasize the high risk for these patients suffering cardiovascular events—particularly acute myocardial infarction—and to the fact that this risk is higher for those patients who need dialysis. Microvascular dysfunction is a constant in patients with Fabry disease, which affects young patients, independently from other cardiac involvement manifestations—such as left ventricular hypertrophy—and from the patient’s gender.
publisher Latin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT)
publishDate 2016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942016000100801
work_keys_str_mv AT cabreragustavo updateoncoronaryinvolvementinfabrydisease
_version_ 1756441180489383936